nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP3A4—bone cancer	0.766	1	CbGaD
Clonidine—Pain in extremity—Epirubicin—bone cancer	0.000547	0.00384	CcSEcCtD
Clonidine—Anxiety—Cisplatin—bone cancer	0.000544	0.00382	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000542	0.00381	CcSEcCtD
Clonidine—Liver function test abnormal—Methotrexate—bone cancer	0.00054	0.00379	CcSEcCtD
Clonidine—Discomfort—Cisplatin—bone cancer	0.00054	0.00379	CcSEcCtD
Clonidine—Breast disorder—Methotrexate—bone cancer	0.000528	0.00371	CcSEcCtD
Clonidine—Oedema—Cisplatin—bone cancer	0.000524	0.00367	CcSEcCtD
Clonidine—Infection—Cisplatin—bone cancer	0.00052	0.00365	CcSEcCtD
Clonidine—Cerebrovascular accident—Doxorubicin—bone cancer	0.000517	0.00363	CcSEcCtD
Clonidine—Lethargy—Doxorubicin—bone cancer	0.000517	0.00363	CcSEcCtD
Clonidine—Nervous system disorder—Cisplatin—bone cancer	0.000513	0.0036	CcSEcCtD
Clonidine—Thrombocytopenia—Cisplatin—bone cancer	0.000513	0.0036	CcSEcCtD
Clonidine—Tachycardia—Cisplatin—bone cancer	0.000511	0.00359	CcSEcCtD
Clonidine—Skin disorder—Cisplatin—bone cancer	0.000509	0.00357	CcSEcCtD
Clonidine—Pain in extremity—Doxorubicin—bone cancer	0.000506	0.00355	CcSEcCtD
Clonidine—Hyperhidrosis—Cisplatin—bone cancer	0.000506	0.00355	CcSEcCtD
Clonidine—Asthma—Methotrexate—bone cancer	0.000505	0.00355	CcSEcCtD
Clonidine—Liver function test abnormal—Epirubicin—bone cancer	0.000505	0.00355	CcSEcCtD
Clonidine—Orthostatic hypotension—Epirubicin—bone cancer	0.0005	0.00351	CcSEcCtD
Clonidine—Abdominal pain upper—Epirubicin—bone cancer	0.0005	0.00351	CcSEcCtD
Clonidine—Anorexia—Cisplatin—bone cancer	0.000499	0.0035	CcSEcCtD
Clonidine—Breast disorder—Epirubicin—bone cancer	0.000494	0.00347	CcSEcCtD
Clonidine—Hypotension—Cisplatin—bone cancer	0.000489	0.00343	CcSEcCtD
Clonidine—Nasopharyngitis—Epirubicin—bone cancer	0.000489	0.00343	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000477	0.00335	CcSEcCtD
Clonidine—Asthma—Epirubicin—bone cancer	0.000473	0.00332	CcSEcCtD
Clonidine—Dysuria—Methotrexate—bone cancer	0.000472	0.00332	CcSEcCtD
Clonidine—Paraesthesia—Cisplatin—bone cancer	0.00047	0.0033	CcSEcCtD
Clonidine—Upper respiratory tract infection—Methotrexate—bone cancer	0.00047	0.0033	CcSEcCtD
Clonidine—Liver function test abnormal—Doxorubicin—bone cancer	0.000467	0.00328	CcSEcCtD
Clonidine—Dyspnoea—Cisplatin—bone cancer	0.000467	0.00328	CcSEcCtD
Clonidine—Erectile dysfunction—Methotrexate—bone cancer	0.000465	0.00327	CcSEcCtD
Clonidine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000462	0.00324	CcSEcCtD
Clonidine—Abdominal pain upper—Doxorubicin—bone cancer	0.000462	0.00324	CcSEcCtD
Clonidine—Breast disorder—Doxorubicin—bone cancer	0.000457	0.00321	CcSEcCtD
Clonidine—Decreased appetite—Cisplatin—bone cancer	0.000455	0.00319	CcSEcCtD
Clonidine—Nasopharyngitis—Doxorubicin—bone cancer	0.000453	0.00318	CcSEcCtD
Clonidine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000452	0.00317	CcSEcCtD
Clonidine—Drowsiness—Methotrexate—bone cancer	0.000451	0.00316	CcSEcCtD
Clonidine—Depression—Methotrexate—bone cancer	0.000449	0.00315	CcSEcCtD
Clonidine—Pain—Cisplatin—bone cancer	0.000448	0.00314	CcSEcCtD
Clonidine—Dysuria—Epirubicin—bone cancer	0.000442	0.0031	CcSEcCtD
Clonidine—Upper respiratory tract infection—Epirubicin—bone cancer	0.000439	0.00308	CcSEcCtD
Clonidine—Asthma—Doxorubicin—bone cancer	0.000438	0.00307	CcSEcCtD
Clonidine—Pollakiuria—Epirubicin—bone cancer	0.000437	0.00307	CcSEcCtD
Clonidine—Sweating—Methotrexate—bone cancer	0.000432	0.00303	CcSEcCtD
Clonidine—Feeling abnormal—Cisplatin—bone cancer	0.000431	0.00303	CcSEcCtD
Clonidine—Weight increased—Epirubicin—bone cancer	0.00043	0.00302	CcSEcCtD
Clonidine—Epistaxis—Methotrexate—bone cancer	0.000425	0.00298	CcSEcCtD
Clonidine—Drowsiness—Epirubicin—bone cancer	0.000422	0.00296	CcSEcCtD
Clonidine—Body temperature increased—Cisplatin—bone cancer	0.000414	0.00291	CcSEcCtD
Clonidine—Urinary tract infection—Epirubicin—bone cancer	0.00041	0.00288	CcSEcCtD
Clonidine—Dysuria—Doxorubicin—bone cancer	0.000409	0.00287	CcSEcCtD
Clonidine—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000407	0.00285	CcSEcCtD
Clonidine—Hepatitis—Methotrexate—bone cancer	0.000404	0.00284	CcSEcCtD
Clonidine—Sweating—Epirubicin—bone cancer	0.000404	0.00284	CcSEcCtD
Clonidine—Pollakiuria—Doxorubicin—bone cancer	0.000404	0.00284	CcSEcCtD
Clonidine—Weight increased—Doxorubicin—bone cancer	0.000398	0.00279	CcSEcCtD
Clonidine—Epistaxis—Epirubicin—bone cancer	0.000398	0.00279	CcSEcCtD
Clonidine—Drowsiness—Doxorubicin—bone cancer	0.00039	0.00274	CcSEcCtD
Clonidine—Hypersensitivity—Cisplatin—bone cancer	0.000386	0.00271	CcSEcCtD
Clonidine—Bradycardia—Epirubicin—bone cancer	0.000385	0.0027	CcSEcCtD
Clonidine—Rhinitis—Epirubicin—bone cancer	0.000379	0.00266	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—bone cancer	0.000379	0.00266	CcSEcCtD
Clonidine—Hepatitis—Epirubicin—bone cancer	0.000378	0.00266	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—bone cancer	0.000378	0.00265	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—bone cancer	0.000377	0.00265	CcSEcCtD
Clonidine—Hypoaesthesia—Epirubicin—bone cancer	0.000377	0.00264	CcSEcCtD
Clonidine—Asthenia—Cisplatin—bone cancer	0.000376	0.00264	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—bone cancer	0.000375	0.00263	CcSEcCtD
Clonidine—Sweating—Doxorubicin—bone cancer	0.000374	0.00262	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—bone cancer	0.000368	0.00258	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—bone cancer	0.000367	0.00258	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—bone cancer	0.000364	0.00256	CcSEcCtD
Clonidine—Diarrhoea—Cisplatin—bone cancer	0.000358	0.00251	CcSEcCtD
Clonidine—Alopecia—Methotrexate—bone cancer	0.000357	0.00251	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—bone cancer	0.000357	0.0025	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—bone cancer	0.000354	0.00249	CcSEcCtD
Clonidine—Eye disorder—Epirubicin—bone cancer	0.000354	0.00248	CcSEcCtD
Clonidine—Tinnitus—Epirubicin—bone cancer	0.000353	0.00248	CcSEcCtD
Clonidine—Erythema—Methotrexate—bone cancer	0.000352	0.00247	CcSEcCtD
Clonidine—Cardiac disorder—Epirubicin—bone cancer	0.000351	0.00247	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—bone cancer	0.000351	0.00246	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—bone cancer	0.00035	0.00246	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—bone cancer	0.000348	0.00245	CcSEcCtD
Clonidine—Angiopathy—Epirubicin—bone cancer	0.000343	0.00241	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—bone cancer	0.000341	0.00239	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—bone cancer	0.000338	0.00237	CcSEcCtD
Clonidine—Alopecia—Epirubicin—bone cancer	0.000334	0.00235	CcSEcCtD
Clonidine—Vomiting—Cisplatin—bone cancer	0.000333	0.00234	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—bone cancer	0.000332	0.00233	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—bone cancer	0.000332	0.00233	CcSEcCtD
Clonidine—Rash—Cisplatin—bone cancer	0.00033	0.00232	CcSEcCtD
Clonidine—Dermatitis—Cisplatin—bone cancer	0.00033	0.00231	CcSEcCtD
Clonidine—Erythema—Epirubicin—bone cancer	0.000329	0.00231	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—bone cancer	0.000327	0.0023	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—bone cancer	0.000327	0.00229	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—bone cancer	0.000327	0.00229	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—bone cancer	0.000325	0.00228	CcSEcCtD
Clonidine—Tension—Epirubicin—bone cancer	0.000323	0.00227	CcSEcCtD
Clonidine—Nervousness—Epirubicin—bone cancer	0.00032	0.00225	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—bone cancer	0.000318	0.00223	CcSEcCtD
Clonidine—Malaise—Methotrexate—bone cancer	0.000317	0.00223	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—bone cancer	0.000317	0.00222	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—bone cancer	0.000316	0.00222	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—bone cancer	0.000313	0.0022	CcSEcCtD
Clonidine—Nausea—Cisplatin—bone cancer	0.000311	0.00218	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—bone cancer	0.000311	0.00218	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—bone cancer	0.000309	0.00217	CcSEcCtD
Clonidine—Cough—Methotrexate—bone cancer	0.000307	0.00216	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—bone cancer	0.000307	0.00215	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—bone cancer	0.000306	0.00215	CcSEcCtD
Clonidine—Erythema—Doxorubicin—bone cancer	0.000305	0.00214	CcSEcCtD
Clonidine—Agitation—Epirubicin—bone cancer	0.000303	0.00213	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—bone cancer	0.0003	0.0021	CcSEcCtD
Clonidine—Chest pain—Methotrexate—bone cancer	0.0003	0.0021	CcSEcCtD
Clonidine—Tension—Doxorubicin—bone cancer	0.000299	0.0021	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000298	0.00209	CcSEcCtD
Clonidine—Malaise—Epirubicin—bone cancer	0.000297	0.00209	CcSEcCtD
Clonidine—Discomfort—Methotrexate—bone cancer	0.000296	0.00208	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—bone cancer	0.000296	0.00208	CcSEcCtD
Clonidine—Syncope—Epirubicin—bone cancer	0.000295	0.00207	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—bone cancer	0.000293	0.00206	CcSEcCtD
Clonidine—Palpitations—Epirubicin—bone cancer	0.000291	0.00204	CcSEcCtD
Clonidine—Confusional state—Methotrexate—bone cancer	0.00029	0.00203	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—bone cancer	0.00029	0.00203	CcSEcCtD
Clonidine—Cough—Epirubicin—bone cancer	0.000288	0.00202	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—bone cancer	0.000287	0.00202	CcSEcCtD
Clonidine—Infection—Methotrexate—bone cancer	0.000285	0.002	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—bone cancer	0.000283	0.00199	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—bone cancer	0.000282	0.00198	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—bone cancer	0.000281	0.00197	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—bone cancer	0.00028	0.00197	CcSEcCtD
Clonidine—Chest pain—Epirubicin—bone cancer	0.00028	0.00197	CcSEcCtD
Clonidine—Agitation—Doxorubicin—bone cancer	0.00028	0.00197	CcSEcCtD
Clonidine—Anxiety—Epirubicin—bone cancer	0.00028	0.00196	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—bone cancer	0.000279	0.00196	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000279	0.00196	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—bone cancer	0.000278	0.00195	CcSEcCtD
Clonidine—Discomfort—Epirubicin—bone cancer	0.000277	0.00195	CcSEcCtD
Clonidine—Malaise—Doxorubicin—bone cancer	0.000275	0.00193	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—bone cancer	0.000274	0.00193	CcSEcCtD
Clonidine—Anorexia—Methotrexate—bone cancer	0.000274	0.00192	CcSEcCtD
Clonidine—Syncope—Doxorubicin—bone cancer	0.000273	0.00192	CcSEcCtD
Clonidine—Confusional state—Epirubicin—bone cancer	0.000271	0.0019	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—bone cancer	0.000269	0.00189	CcSEcCtD
Clonidine—Oedema—Epirubicin—bone cancer	0.000269	0.00189	CcSEcCtD
Clonidine—Hypotension—Methotrexate—bone cancer	0.000268	0.00188	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—bone cancer	0.000268	0.00188	CcSEcCtD
Clonidine—Infection—Epirubicin—bone cancer	0.000267	0.00187	CcSEcCtD
Clonidine—Cough—Doxorubicin—bone cancer	0.000266	0.00187	CcSEcCtD
Clonidine—Shock—Epirubicin—bone cancer	0.000265	0.00186	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—bone cancer	0.000264	0.00185	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—bone cancer	0.000263	0.00185	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—bone cancer	0.000262	0.00184	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000262	0.00184	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—bone cancer	0.000261	0.00183	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—bone cancer	0.00026	0.00182	CcSEcCtD
Clonidine—Insomnia—Methotrexate—bone cancer	0.00026	0.00182	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—bone cancer	0.00026	0.00182	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—bone cancer	0.00026	0.00182	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—bone cancer	0.000259	0.00182	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—bone cancer	0.000258	0.00181	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000258	0.00181	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—bone cancer	0.000256	0.0018	CcSEcCtD
Clonidine—Anorexia—Epirubicin—bone cancer	0.000256	0.0018	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—bone cancer	0.000256	0.0018	CcSEcCtD
Clonidine—Somnolence—Methotrexate—bone cancer	0.000255	0.00179	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—bone cancer	0.000254	0.00178	CcSEcCtD
Clonidine—Hypotension—Epirubicin—bone cancer	0.000251	0.00176	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—bone cancer	0.000251	0.00176	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—bone cancer	0.00025	0.00175	CcSEcCtD
Clonidine—Oedema—Doxorubicin—bone cancer	0.000249	0.00175	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000248	0.00174	CcSEcCtD
Clonidine—Fatigue—Methotrexate—bone cancer	0.000248	0.00174	CcSEcCtD
Clonidine—Infection—Doxorubicin—bone cancer	0.000247	0.00173	CcSEcCtD
Clonidine—Pain—Methotrexate—bone cancer	0.000246	0.00172	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000245	0.00172	CcSEcCtD
Clonidine—Shock—Doxorubicin—bone cancer	0.000245	0.00172	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—bone cancer	0.000244	0.00171	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—bone cancer	0.000244	0.00171	CcSEcCtD
Clonidine—Insomnia—Epirubicin—bone cancer	0.000243	0.00171	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—bone cancer	0.000243	0.0017	CcSEcCtD
Clonidine—Diclofenac—CYP3A4—bone cancer	0.000242	0.505	CrCbGaD
Clonidine—Skin disorder—Doxorubicin—bone cancer	0.000242	0.0017	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—bone cancer	0.000241	0.00169	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—bone cancer	0.000241	0.00169	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—bone cancer	0.00024	0.00168	CcSEcCtD
Clonidine—Somnolence—Epirubicin—bone cancer	0.000239	0.00168	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—bone cancer	0.000237	0.00166	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—bone cancer	0.000237	0.00166	CcSEcCtD
Clonidine—Diclofenac—PTGS2—bone cancer	0.000237	0.495	CrCbGaD
Clonidine—Gastrointestinal pain—Methotrexate—bone cancer	0.000235	0.00165	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—bone cancer	0.000234	0.00164	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—bone cancer	0.000232	0.00163	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000232	0.00163	CcSEcCtD
Clonidine—Fatigue—Epirubicin—bone cancer	0.000232	0.00163	CcSEcCtD
Clonidine—Pain—Epirubicin—bone cancer	0.00023	0.00161	CcSEcCtD
Clonidine—Constipation—Epirubicin—bone cancer	0.00023	0.00161	CcSEcCtD
Clonidine—Urticaria—Methotrexate—bone cancer	0.000228	0.0016	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—bone cancer	0.000227	0.00159	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—bone cancer	0.000227	0.00159	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000227	0.00159	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—bone cancer	0.000225	0.00158	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—bone cancer	0.000223	0.00157	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—bone cancer	0.000222	0.00156	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—bone cancer	0.000222	0.00156	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—bone cancer	0.000221	0.00155	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—bone cancer	0.00022	0.00154	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—bone cancer	0.000216	0.00152	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000215	0.00151	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—bone cancer	0.000215	0.00151	CcSEcCtD
Clonidine—Urticaria—Epirubicin—bone cancer	0.000214	0.0015	CcSEcCtD
Clonidine—Pain—Doxorubicin—bone cancer	0.000213	0.00149	CcSEcCtD
Clonidine—Constipation—Doxorubicin—bone cancer	0.000213	0.00149	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—bone cancer	0.000213	0.00149	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—bone cancer	0.000213	0.00149	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—bone cancer	0.000212	0.00149	CcSEcCtD
Clonidine—Asthenia—Methotrexate—bone cancer	0.000206	0.00145	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—bone cancer	0.000205	0.00144	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000203	0.00143	CcSEcCtD
Clonidine—Pruritus—Methotrexate—bone cancer	0.000203	0.00143	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—bone cancer	0.000198	0.00139	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—bone cancer	0.000198	0.00139	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—bone cancer	0.000197	0.00138	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—bone cancer	0.000197	0.00138	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—bone cancer	0.000197	0.00138	CcSEcCtD
Clonidine—Asthenia—Epirubicin—bone cancer	0.000193	0.00135	CcSEcCtD
Clonidine—Pruritus—Epirubicin—bone cancer	0.00019	0.00134	CcSEcCtD
Clonidine—Dizziness—Methotrexate—bone cancer	0.00019	0.00133	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—bone cancer	0.000184	0.00129	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—bone cancer	0.000183	0.00129	CcSEcCtD
Clonidine—Vomiting—Methotrexate—bone cancer	0.000183	0.00128	CcSEcCtD
Clonidine—Rash—Methotrexate—bone cancer	0.000181	0.00127	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—bone cancer	0.000181	0.00127	CcSEcCtD
Clonidine—Headache—Methotrexate—bone cancer	0.00018	0.00126	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—bone cancer	0.000179	0.00125	CcSEcCtD
Clonidine—Dizziness—Epirubicin—bone cancer	0.000178	0.00125	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—bone cancer	0.000176	0.00124	CcSEcCtD
Clonidine—Vomiting—Epirubicin—bone cancer	0.000171	0.0012	CcSEcCtD
Clonidine—Nausea—Methotrexate—bone cancer	0.000171	0.0012	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—bone cancer	0.00017	0.00119	CcSEcCtD
Clonidine—Rash—Epirubicin—bone cancer	0.00017	0.00119	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—bone cancer	0.000169	0.00119	CcSEcCtD
Clonidine—Headache—Epirubicin—bone cancer	0.000168	0.00118	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—bone cancer	0.000165	0.00115	CcSEcCtD
Clonidine—Nausea—Epirubicin—bone cancer	0.00016	0.00112	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—bone cancer	0.000158	0.00111	CcSEcCtD
Clonidine—Rash—Doxorubicin—bone cancer	0.000157	0.0011	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—bone cancer	0.000157	0.0011	CcSEcCtD
Clonidine—Headache—Doxorubicin—bone cancer	0.000156	0.00109	CcSEcCtD
Clonidine—Nausea—Doxorubicin—bone cancer	0.000148	0.00104	CcSEcCtD
Clonidine—ADRA2B—Signaling by GPCR—GRM1—bone cancer	9.49e-05	0.00104	CbGpPWpGaD
Clonidine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	9.46e-05	0.00104	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	9.24e-05	0.00101	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.21e-05	0.00101	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	9.15e-05	0.001	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	9.15e-05	0.001	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—IL3—bone cancer	9.03e-05	0.000988	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NDUFA12—bone cancer	9.02e-05	0.000987	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—GRM4—bone cancer	8.94e-05	0.000979	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—RGS1—bone cancer	8.94e-05	0.000979	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—GRM1—bone cancer	8.87e-05	0.000971	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—SPARC—bone cancer	8.84e-05	0.000968	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—GRM1—bone cancer	8.73e-05	0.000955	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	8.66e-05	0.000948	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	8.66e-05	0.000948	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—NT5C3A—bone cancer	8.63e-05	0.000945	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	8.54e-05	0.000934	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	8.35e-05	0.000915	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—GRM4—bone cancer	8.31e-05	0.000909	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—RGS1—bone cancer	8.31e-05	0.000909	CbGpPWpGaD
Clonidine—CYP1A2—Biological oxidations—GSTP1—bone cancer	8.21e-05	0.000898	CbGpPWpGaD
Clonidine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	8.09e-05	0.000886	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—GNA11—bone cancer	8.09e-05	0.000885	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.95e-05	0.000871	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	7.93e-05	0.000868	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—NT5C3A—bone cancer	7.91e-05	0.000866	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—GRM1—bone cancer	7.75e-05	0.000849	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—BRAF—bone cancer	7.64e-05	0.000836	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—ENO2—bone cancer	7.63e-05	0.000835	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NT5C3A—bone cancer	7.47e-05	0.000818	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—GNA11—bone cancer	7.46e-05	0.000817	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—SMO—bone cancer	7.41e-05	0.000811	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—IL3—bone cancer	7.33e-05	0.000803	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NDUFA12—bone cancer	7.2e-05	0.000789	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—GRM1—bone cancer	7.2e-05	0.000788	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—GRM4—bone cancer	7.16e-05	0.000784	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—RGS1—bone cancer	7.16e-05	0.000784	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—DHFR—bone cancer	7.08e-05	0.000775	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.85e-05	0.00075	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NDUFA12—bone cancer	6.79e-05	0.000743	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—GNA11—bone cancer	6.77e-05	0.000742	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—IL3—bone cancer	6.76e-05	0.00074	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—GNA11—bone cancer	6.74e-05	0.000737	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—SMO—bone cancer	6.69e-05	0.000732	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	6.67e-05	0.00073	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—GNA11—bone cancer	6.62e-05	0.000724	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—RGS1—bone cancer	6.47e-05	0.000708	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—GRM4—bone cancer	6.47e-05	0.000708	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—MDM2—bone cancer	6.4e-05	0.000701	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—PLAU—bone cancer	6.34e-05	0.000694	CbGpPWpGaD
Clonidine—CYP3A4—Biological oxidations—GSTP1—bone cancer	6.33e-05	0.000693	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—GNA11—bone cancer	6.29e-05	0.000689	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—SMO—bone cancer	6.25e-05	0.000684	CbGpPWpGaD
Clonidine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.25e-05	0.000684	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—GRM1—bone cancer	6.21e-05	0.00068	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—GNA11—bone cancer	6.19e-05	0.000678	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—SMO—bone cancer	6.15e-05	0.000673	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL3—bone cancer	6.14e-05	0.000672	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—GNA11—bone cancer	6.12e-05	0.00067	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—IL3—bone cancer	6.11e-05	0.000669	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—RGS1—bone cancer	6.04e-05	0.000661	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—GRM4—bone cancer	6.04e-05	0.000661	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—CYP3A4—bone cancer	6e-05	0.000657	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NT5C3A—bone cancer	5.97e-05	0.000654	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—GRM4—bone cancer	5.95e-05	0.000651	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—RGS1—bone cancer	5.95e-05	0.000651	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—PLAU—bone cancer	5.92e-05	0.000648	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NDUFA12—bone cancer	5.75e-05	0.00063	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—GNA11—bone cancer	5.71e-05	0.000626	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—IL3—bone cancer	5.7e-05	0.000624	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NT5C3A—bone cancer	5.63e-05	0.000616	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—GNA11—bone cancer	5.62e-05	0.000616	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—IL3—bone cancer	5.61e-05	0.000615	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—GRM1—bone cancer	5.61e-05	0.000614	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL3—bone cancer	5.55e-05	0.000607	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	5.53e-05	0.000606	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	5.5e-05	0.000602	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—SMO—bone cancer	5.46e-05	0.000598	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RGS1—bone cancer	5.28e-05	0.000578	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GRM4—bone cancer	5.28e-05	0.000578	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—GRM1—bone cancer	5.24e-05	0.000573	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL3—bone cancer	5.18e-05	0.000567	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—GRM1—bone cancer	5.15e-05	0.000564	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—GSTP1—bone cancer	5.13e-05	0.000562	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	5.11e-05	0.000559	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL3—bone cancer	5.1e-05	0.000558	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.08e-05	0.000556	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—SMO—bone cancer	5.07e-05	0.000555	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—GNA11—bone cancer	4.99e-05	0.000547	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—IL3—bone cancer	4.99e-05	0.000546	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	4.91e-05	0.000538	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GRM4—bone cancer	4.91e-05	0.000537	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RGS1—bone cancer	4.91e-05	0.000537	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.9e-05	0.000536	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—PLAU—bone cancer	4.81e-05	0.000526	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NT5C3A—bone cancer	4.77e-05	0.000522	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—ENO2—bone cancer	4.66e-05	0.00051	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	4.64e-05	0.000508	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	4.63e-05	0.000507	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GRM1—bone cancer	4.58e-05	0.000501	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL3—bone cancer	4.53e-05	0.000496	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—ENO2—bone cancer	4.46e-05	0.000488	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NDUFA12—bone cancer	4.44e-05	0.000486	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.42e-05	0.000483	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SMO—bone cancer	4.38e-05	0.000479	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—DHFR—bone cancer	4.32e-05	0.000473	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GRM1—bone cancer	4.25e-05	0.000466	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL3—bone cancer	4.21e-05	0.000461	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—DHFR—bone cancer	4.14e-05	0.000453	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—GNA11—bone cancer	4.04e-05	0.000442	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—GNA11—bone cancer	4e-05	0.000438	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SMO—bone cancer	3.95e-05	0.000433	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—GNA11—bone cancer	3.87e-05	0.000423	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ENO2—bone cancer	3.78e-05	0.000414	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—ATF1—bone cancer	3.72e-05	0.000407	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SMO—bone cancer	3.69e-05	0.000404	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NT5C3A—bone cancer	3.68e-05	0.000403	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CYP3A4—bone cancer	3.66e-05	0.000401	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SMO—bone cancer	3.63e-05	0.000398	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL3—bone cancer	3.63e-05	0.000397	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—GNA11—bone cancer	3.61e-05	0.000396	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—DHFR—bone cancer	3.51e-05	0.000384	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CYP3A4—bone cancer	3.51e-05	0.000384	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.47e-05	0.00038	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ENO2—bone cancer	3.47e-05	0.000379	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—GNA11—bone cancer	3.38e-05	0.00037	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ATF1—bone cancer	3.36e-05	0.000368	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—GNA11—bone cancer	3.32e-05	0.000364	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—GNA11—bone cancer	3.28e-05	0.000359	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL3—bone cancer	3.28e-05	0.000359	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ENO2—bone cancer	3.27e-05	0.000358	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SMO—bone cancer	3.23e-05	0.000353	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—DHFR—bone cancer	3.21e-05	0.000352	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ATF1—bone cancer	3.14e-05	0.000344	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—GSTP1—bone cancer	3.13e-05	0.000343	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	3.1e-05	0.00034	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ATF1—bone cancer	3.09e-05	0.000338	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL3—bone cancer	3.06e-05	0.000335	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—DHFR—bone cancer	3.04e-05	0.000332	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL3—bone cancer	3.01e-05	0.00033	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—GNA11—bone cancer	3e-05	0.000329	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—GSTP1—bone cancer	3e-05	0.000328	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SMO—bone cancer	3e-05	0.000328	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CYP3A4—bone cancer	2.97e-05	0.000325	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.95e-05	0.000323	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IGF1R—bone cancer	2.92e-05	0.00032	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.91e-05	0.000319	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—GNA11—bone cancer	2.84e-05	0.000311	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	2.8e-05	0.000307	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.74e-05	0.0003	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.74e-05	0.0003	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CYP3A4—bone cancer	2.72e-05	0.000298	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL3—bone cancer	2.67e-05	0.000293	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PTGS2—bone cancer	2.66e-05	0.000291	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IGF1R—bone cancer	2.64e-05	0.000289	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	2.62e-05	0.000287	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ENO2—bone cancer	2.61e-05	0.000286	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.58e-05	0.000282	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CYP3A4—bone cancer	2.57e-05	0.000282	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.56e-05	0.00028	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.55e-05	0.000279	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—bone cancer	2.55e-05	0.000279	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—GSTP1—bone cancer	2.54e-05	0.000278	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL3—bone cancer	2.49e-05	0.000272	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ENO2—bone cancer	2.46e-05	0.00027	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IGF1R—bone cancer	2.46e-05	0.00027	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—DHFR—bone cancer	2.43e-05	0.000266	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.42e-05	0.000265	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—bone cancer	2.38e-05	0.000261	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—GSTP1—bone cancer	2.33e-05	0.000255	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.29e-05	0.00025	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—DHFR—bone cancer	2.29e-05	0.00025	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GNA11—bone cancer	2.27e-05	0.000248	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—GSTP1—bone cancer	2.2e-05	0.000241	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	2.15e-05	0.000236	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GNA11—bone cancer	2.14e-05	0.000234	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	2.13e-05	0.000233	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KIT—bone cancer	2.12e-05	0.000232	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ENO2—bone cancer	2.09e-05	0.000229	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP3A4—bone cancer	2.06e-05	0.000225	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	2e-05	0.000219	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.99e-05	0.000218	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.94e-05	0.000212	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—DHFR—bone cancer	1.94e-05	0.000212	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—bone cancer	1.93e-05	0.000212	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.93e-05	0.000211	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KIT—bone cancer	1.91e-05	0.000209	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GNA11—bone cancer	1.81e-05	0.000198	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.8e-05	0.000197	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KIT—bone cancer	1.79e-05	0.000196	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GSTP1—bone cancer	1.76e-05	0.000192	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KIT—bone cancer	1.76e-05	0.000192	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.74e-05	0.000191	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.68e-05	0.000184	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.67e-05	0.000183	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GSTP1—bone cancer	1.66e-05	0.000181	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.65e-05	0.000181	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.64e-05	0.00018	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.63e-05	0.000179	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.63e-05	0.000178	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—bone cancer	1.62e-05	0.000178	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ENO2—bone cancer	1.61e-05	0.000176	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.6e-05	0.000175	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.56e-05	0.000171	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—bone cancer	1.55e-05	0.00017	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.51e-05	0.000165	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—DHFR—bone cancer	1.49e-05	0.000164	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.47e-05	0.000161	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KIT—bone cancer	1.45e-05	0.000159	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—JUN—bone cancer	1.45e-05	0.000159	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.42e-05	0.000156	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.41e-05	0.000154	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.41e-05	0.000154	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTP1—bone cancer	1.4e-05	0.000154	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GNA11—bone cancer	1.4e-05	0.000153	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.38e-05	0.000152	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.36e-05	0.000149	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.32e-05	0.000145	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—bone cancer	1.32e-05	0.000144	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—JUN—bone cancer	1.31e-05	0.000143	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.27e-05	0.000139	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.23e-05	0.000135	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—JUN—bone cancer	1.22e-05	0.000134	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—bone cancer	1.21e-05	0.000132	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—JUN—bone cancer	1.2e-05	0.000132	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—bone cancer	1.19e-05	0.00013	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.17e-05	0.000128	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.14e-05	0.000125	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—bone cancer	1.14e-05	0.000125	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—bone cancer	1.14e-05	0.000125	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTP1—bone cancer	1.08e-05	0.000119	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—JUN—bone cancer	1.07e-05	0.000117	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—bone cancer	1.04e-05	0.000114	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—bone cancer	1.03e-05	0.000113	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—JUN—bone cancer	9.93e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—bone cancer	9.66e-06	0.000106	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—bone cancer	9.61e-06	0.000105	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—bone cancer	9.57e-06	0.000105	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—bone cancer	9.46e-06	0.000104	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—bone cancer	9.11e-06	9.97e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—bone cancer	8.64e-06	9.46e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—bone cancer	8.58e-06	9.4e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—bone cancer	8.4e-06	9.2e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—bone cancer	8.07e-06	8.83e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—bone cancer	7.94e-06	8.69e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—bone cancer	7.81e-06	8.55e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—bone cancer	7.27e-06	7.96e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—bone cancer	7.05e-06	7.72e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—bone cancer	6.55e-06	7.18e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—bone cancer	5.61e-06	6.14e-05	CbGpPWpGaD
